Stockreport

Alkermes Presents Data Demonstrating Safety and Gastrointestinal Tolerability Profile of ALKS 8700 for the Treatment of Multiple Sclerosis

Alkermes plc - Ordinary Shares  (ALKS) 
Last alkermes plc - ordinary shares earnings: 4/29 07:00 am Check Earnings Report
PDF –– Data From More Than 570 Patients in Ongoing Long-Term Safety Study of ALKS 8700 Demonstrate Low Rates of Discontinuation During Initial Three Months o [Read more]